Adia Nutrition Joins PI Doctors Elite Community as Preferred Vendor Unlocking Access to a $50 Billion Personal Injury Care Market
Adia Nutrition (OTCQB: ADIA) has been selected as a preferred vendor for the PI Doctors Elite Community, gaining access to a network of over 4,000 personal injury physicians across the United States. This strategic partnership positions Adia Labs to tap into the $50 billion personal injury care market.
Through this partnership, Adia Labs will provide its regenerative products, including AdiaVita and AdiaLink, to physicians treating injury-related conditions. A key advantage is that these therapies may be covered by auto insurance when prescribed, bypassing traditional health insurance requirements.
The partnership follows Adia's recent expansion into the $25 billion wound care market and complements their national television campaign promoting regenerative solutions.
Adia Nutrition (OTCQB: ADIA) è stata scelta come fornitore preferenziale per la PI Doctors Elite Community, ottenendo l'accesso a una rete di oltre 4.000 medici specializzati in lesioni personali negli Stati Uniti. Questa partnership strategica mette Adia Labs in posizione di sfruttare il mercato della cura delle lesioni personali del valore di 50 miliardi di dollari.
Grazie all'accordo, Adia Labs fornirà ai medici che trattano condizioni legate alle lesioni i suoi prodotti rigenerativi, inclusi AdiaVita e AdiaLink. Un vantaggio chiave è che queste terapie, se prescritte, possono essere coperte dall'assicurazione auto, evitando i requisiti della tradizionale assicurazione sanitaria.
La partnership segue l'espansione recente di Adia nel mercato della cura delle ferite da 25 miliardi di dollari e integra la loro campagna televisiva nazionale a sostegno delle soluzioni rigenerative.
Adia Nutrition (OTCQB: ADIA) ha sido seleccionada como proveedor preferente para la PI Doctors Elite Community, obteniendo acceso a una red de más de 4.000 médicos especializados en lesiones personales en todo Estados Unidos. Esta alianza estratégica posiciona a Adia Labs para aprovechar el mercado de atención a lesiones personales de 50.000 millones de dólares.
Mediante esta colaboración, Adia Labs suministrará sus productos regenerativos, incluidos AdiaVita y AdiaLink, a médicos que tratan afecciones relacionadas con lesiones. Una ventaja importante es que estas terapias, cuando se prescriben, pueden estar cubiertas por el seguro de automóvil, eludiendo los requisitos del seguro médico tradicional.
La asociación sigue a la reciente expansión de Adia en el mercado del cuidado de heridas de 25.000 millones de dólares y complementa su campaña televisiva nacional que promueve soluciones regenerativas.
Adia Nutrition (OTCQB: ADIA)가 PI Doctors Elite Community의 우선 공급업체로 선정되어 미국 전역의 4,000명 이상의 개인 상해 전문 의사 네트워크에 접근하게 되었습니다. 이 전략적 파트너십은 Adia Labs가 500억 달러 규모의 개인 상해 치료 시장에 진입할 수 있는 기반을 마련합니다.
이번 협력을 통해 Adia Labs는 AdiaVita와 AdiaLink를 포함한 재생 의학 제품을 부상 관련 질환을 치료하는 의사들에게 제공할 예정입니다. 주요 이점은 이러한 치료법이 처방될 경우 자동차 보험으로 보장될 수 있어 기존의 건강보험 요건을 우회할 수 있다는 점입니다.
이번 파트너십은 Adia가 최근 250억 달러 규모의 상처 치료 시장으로 확장한 데 따른 것이며, 재생 솔루션을 홍보하는 전국 TV 캠페인과도 시너지를 이룹니다.
Adia Nutrition (OTCQB: ADIA) a été sélectionnée comme fournisseur privilégié de la PI Doctors Elite Community, obtenant ainsi l'accès à un réseau de plus de 4 000 médecins spécialisés en traumatologie à travers les États-Unis. Ce partenariat stratégique place Adia Labs en position d'exploiter le marché des soins aux blessures personnelles estimé à 50 milliards de dollars.
Dans le cadre de ce partenariat, Adia Labs fournira ses produits régénératifs, notamment AdiaVita et AdiaLink, aux médecins traitant des affections liées aux blessures. Un avantage clé est que ces thérapies, lorsqu'elles sont prescrites, peuvent être prises en charge par l'assurance automobile, contournant ainsi les exigences des assurances santé traditionnelles.
Ce partenariat fait suite à l'expansion récente d'Adia sur le marché des soins des plaies de 25 milliards de dollars et complète leur campagne télévisée nationale promouvant les solutions régénératives.
Adia Nutrition (OTCQB: ADIA) wurde als bevorzugter Anbieter für die PI Doctors Elite Community ausgewählt und erhält Zugang zu einem Netzwerk von über 4.000 Fachärzten für Personenschäden in den Vereinigten Staaten. Diese strategische Partnerschaft positioniert Adia Labs, um den 50-Milliarden-Dollar-Markt für Versorgung bei Personenschäden zu erschließen.
Im Rahmen der Partnerschaft wird Adia Labs Ärzten, die verletzungsbedingte Beschwerden behandeln, seine regenerativen Produkte, darunter AdiaVita und AdiaLink, bereitstellen. Ein wesentlicher Vorteil ist, dass diese Therapien bei Verordnung durch die Autoversicherung abgedeckt werden können und somit die Anforderungen traditioneller Krankenversicherungen umgehen.
Die Kooperation folgt Adias jüngster Expansion in den 25-Milliarden-Dollar-Wundversorgungsmarkt und ergänzt ihre landesweite Fernsehkampagne zur Förderung regenerativer Lösungen.
- Access to network of over 4,000 personal injury physicians nationwide
- Entry into $50 billion personal injury care market
- Products may be covered by auto insurance, simplifying payment process
- Expanded distribution channel for AdiaVita and AdiaLink products
- Potential for increased product sales through direct supply to physician network
- None.
Winter Park, Florida--(Newsfile Corp. - August 28, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company focused on regenerative medicine and personalized healthcare, announced that its laboratory division, Adia Labs, has been selected as a preferred vendor for the PI Doctors Elite Community. This national network includes over 4,000 personal injury physicians across various specialties, providing Adia Labs with access to a robust referral base serving injury patients throughout the United States.
This milestone follows Adia's recent initiatives, including its expansion into the
The personal injury care industry, valued at approximately
"Joining the PI Doctors Elite Community as a preferred vendor connects Adia Labs with a national network of over 4000 physicians who can utilize AdiaLabs Products," said Larry Powalisz, CEO of Adia Nutrition Inc. "This partnership complements our national campaign and expands our network to include auto insurance providers, advancing our strategy to access high-value patient markets."
As part of the partnership, Adia recently participated in a featured podcast with the PI Doctors Elite Community, discussing the role of regenerative science in personal injury care and how Adia Labs provides high-quality, U.S.-based regenerative products to clinics nationwide. Link to Podcast
Through this partnership, Adia Labs connects with a diverse network of healthcare providers, including orthopedic surgeons, chiropractors, neurologists, and pain specialists, who treat cases that could benefit from Adia's regenerative and diagnostic technologies. As a preferred vendor, Adia Labs is well-positioned to supply AdiaVita and AdiaLink directly to this community of physicians, driving increased product sales.
For questions, inquiries, or additional information, please contact Larry Powalisz at ceo@adiamed.com or by phone at 321-788-0850.
Clinic owners and healthcare practitioners interested in licensing the Adia Med name or integrating Adia's regenerative therapies into their practice are encouraged to reach out directly. Strategic partnerships are welcomed as part of Adia's continued mission to expand access to advanced stem cell solutions.
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTCQB: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
Website: www.adianutrition.com
Website: www.adiamed.com
Website: www.adialabs.com
Website: www.biolete.com
Website: www.cementfactory.co
Twitter (X): @ADIA_Nutrition
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/264104
FAQ
What is the significance of Adia Nutrition's partnership with PI Doctors Elite Community?
What products will ADIA provide through the PI Doctors Elite network?
How will insurance coverage work for ADIA's products in personal injury cases?
What is the size of the market ADIA is targeting with this partnership?
Who can physicians contact for information about ADIA's products and partnerships?
